Last update 09 Dec 2025

SARS-CoV-2 multi-epitope vaccine(Medical University of Sofia)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
COVID-19
Inactive Indication-
Originator Organization
Medical University SofiaMedical University Sofia
Active Organization
Medical University SofiaMedical University Sofia
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

9
Clinical Trials associated with SARS-CoV-2 multi-epitope vaccine(Medical University of Sofia)
CTIS2023-508458-25-00
/ CompletedPhase 2/3
A Phase IIb/III, Double-Blind, Randomised, Active-Controlled, Multi-Center, Non-Inferiority Clinical Trial, to assess the safety and immunogenicity of a booster vaccination with an adapted recombinant protein RBD fusion homodimer candidate (PHH-1V81) against SARS-CoV-2, in adults vaccinated against COVID-19.
ChiCTR2300072396
/ CompletedPhase 1IIT
A randomised, double-blinded, active-controlled clinical trial to evaluate the safety and immunogenicity of heterologous boost with a Bivalent SARS-CoV-2 mRNA Vaccine in the participants aged 18 years or more who have previously received SARS-CoV-2 vaccine
ChiCTR2200063935
/ CompletedNot ApplicableIIT
A Preliminary Exploratory Cohort Study to Evaluate Safety, Tolerability and Immunogenicity of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine (LVRNA012) in Participants Aged 18 Years and Over in China
100 Clinical Results associated with SARS-CoV-2 multi-epitope vaccine(Medical University of Sofia)
Login to view more data
100 Translational Medicine associated with SARS-CoV-2 multi-epitope vaccine(Medical University of Sofia)
Login to view more data
100 Patents (Medical) associated with SARS-CoV-2 multi-epitope vaccine(Medical University of Sofia)
Login to view more data
100 Deals associated with SARS-CoV-2 multi-epitope vaccine(Medical University of Sofia)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Preclinical
Bulgaria
Medical University SofiaMedical University Sofia
07 Nov 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free